Although the origins of the sex-specific differences in carcinogenesis may ultimately be different than sex-specific differences in the manifestation of metabolic syndrome in NEIL1-deficient mice, pathways regulating obesity, fatty liver disease, and insulin resistance may also have significant overlap with drivers of carcinogenesis. This evidence concerns the gene NEIL1 and metabolic syndrome.